Publicaciones en las que colabora con Bárbara Angulo Biedma (12)

2019

  1. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

    Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132

2018

  1. Aligning digital CD8 + scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma

    Histopathology, Vol. 72, Núm. 2, pp. 270-284

2013

  1. Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib

    PLoS ONE, Vol. 8, Núm. 1

  2. Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

    Journal of Clinical Pathology, Vol. 66, Núm. 5, pp. 381-385

  3. Lung adenocarcinoma in the era of targeted therapies: Histological classification, sample prioritization, and predictive biomarkers

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 503-508

  4. The ALK translocation in advanced non-small-cell lung carcinomas: Preapproval testing experience at a single cancer centre

    Histopathology, Vol. 62, Núm. 4, pp. 609-616

2012

  1. A comparison of EGFR mutation testing methods in lung carcinoma: Direct sequencing, real-time PCR and immunohistochemistry

    PLoS ONE, Vol. 7, Núm. 8

2011

  1. Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: A comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method

    Histopathology, Vol. 59, Núm. 1, pp. 8-17

2010

  1. A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: A morphology-based approach in colorectal carcinoma

    Journal of Molecular Diagnostics, Vol. 12, Núm. 3, pp. 292-299

  2. The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung

    PLoS ONE, Vol. 5, Núm. 8

2008

  1. Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification

    Journal of Pathology, Vol. 214, Núm. 3, pp. 347-356

2006

  1. Molecular context of the EGFR mutations: Evidence for the activation of mTOR/S6K signaling

    Clinical Cancer Research, Vol. 12, Núm. 3 I, pp. 710-717